Palantir’s, Government

Palantir’s Government Tug-of-War: DHS Renewal and Record Revenue vs. London Block and DIA Legal Fight

22.05.2026 - 18:24:03 | boerse-global.de

Despite a strong Q1 earnings beat, Palantir's stock faces headwinds from a blocked London police contract and a new lawsuit, though a DHS renewal boosts outlook.

Palantir’s Government Tug-of-War: DHS Renewal and Record Revenue vs. London Block and DIA Legal Fight - Foto: über boerse-global.de
Palantir’s Government Tug-of-War: DHS Renewal and Record Revenue vs. London Block and DIA Legal Fight - Foto: über boerse-global.de

Palantir Technologies finds itself pulled in opposite directions as a major U.S. government contract extension coincides with a blocked deal in London and a fresh lawsuit against a Pentagon agency. The data analytics company’s shares are trading at roughly €118, some 14-15% below their 200-day moving average, with a year-to-date decline of around 17-18% — despite first-quarter numbers that handily beat expectations.

The most recent win came from the Department of Homeland Security, which renewed an $86 million contract for ImmigrationOS, the software used by ICE to manage immigration data. The new agreement runs through spring 2027 and sits inside a multi-billion-dollar framework deal with the DHS. The renewal followed a May 2026 internal “Hack Week” during which Palantir engineers built enhanced session logs and automated alerts to give departments greater oversight of user activity — a direct response to internal debates over ethical standards in immigration enforcement.

Across the Atlantic, the picture is less favourable. On 22 May 2026, London Mayor Sadiq Khan blocked a £50 million AI contract between the Metropolitan Police and Palantir, citing a clear breach of procurement rules — no competitive tender and no value-for-money assessment. The deal, which would have modernised the Met’s data infrastructure and generated £15-25 million annually, was sharply criticised by Palantir’s UK leadership, who accused the mayor of prioritising politics over public safety. The company still has over £600 million in UK contracts with the NHS and the Ministry of Defence, but the London setback chips away at its civilian government footprint.

Should investors sell immediately? Or is it worth buying Palantir?

On a separate U.S. front, Palantir has gone on the offensive, filing a lawsuit against the Defense Intelligence Agency over the MARS programme — an eight-year project meant to modernise military data analysis. The company alleges the DIA is violating federal law by building its own systems when commercial alternatives exist, effectively wasting taxpayer money. Some senior security officials have publicly backed Palantir’s position.

The operational engine, however, continues to hum. For the first quarter of 2026, Palantir posted adjusted earnings per share of $0.33, well above the $0.28 consensus, on revenue of $1.633 billion — an 85% year-over-year surge. The Rule of 40 metric hit 145%, fuelled by that top-line growth and a 60% adjusted operating margin. For the third quarter, management guided for EPS of $0.37 on revenue of $1.8 billion.

Wall Street remains cautiously optimistic. The average analyst price target sits around $195, roughly 42% above current levels. Citigroup and Rosenblatt both have $225 targets, Wedbush is at $230, and Freedom Broker recently lifted its own target to $230. Cantor Fitzgerald, however, sticks with a Neutral rating and a $138 target, flagging the stock’s 154-times price-to-earnings ratio as the primary risk. The consensus stands at “Moderate Buy”.

With a market capitalisation of approximately $329 billion, Palantir’s valuation leaves little room for error. Whether the strong growth trajectory can offset the legal and regulatory drags — and whether other governments follow London’s lead — remains the central question. The next quarterly report is due on 10 August.

Ad

Palantir Stock: New Analysis - 22 May

Fresh Palantir information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated Palantir analysis...

So schätzen die Börsenprofis Palantir’s Aktien ein!

<b>So schätzen die Börsenprofis  Palantir’s Aktien ein!</b>
Seit 2005 liefert der Börsenbrief trading-notes verlässliche Anlage-Empfehlungen – dreimal pro Woche, direkt ins Postfach. 100% kostenlos. 100% Expertenwissen. Trage einfach deine E-Mail Adresse ein und verpasse ab heute keine Top-Chance mehr. Jetzt abonnieren.
Für. Immer. Kostenlos.
en | US69608A1088 | PALANTIR’S | boerse | 69402754 |